Common questions about ДуоРесп Спиромакс (FAQ)
Q: What is the main difference between ДуоРесп Спиромакс and other common asthma inhalers?
A: ДуоРесп Спиромакс is a fixed-dose combination medicine that pairs a long-acting bronchodilator with an inhaled corticosteroid. It is distinguished by its delivery system, the Spiromax device, which is a type of dry powder inhaler (DPI) designed for efficient delivery through a breath-actuated mechanism, differing from metered-dose or other powder inhaler designs.
Q: How quickly should I feel the breathing-improvement effect after using ДуоРесп Спиромакс?
A: The Formoterol component in the medicine is a fast-acting bronchodilator that provides rapid relief by relaxing the bronchial smooth muscle. While official documents describe this as a swift signaling event, the exact time (e.g., within minutes) before the initial breathing improvement is felt is not typically quantified in patient information.
Q: Is ДуоРесп Спиромакс a 'preventer' or a 'reliever' medicine, or both?
A: It can be prescribed for both roles, depending on the dosage regimen. It is primarily used as a long-term maintenance (or 'preventer') treatment due to the anti-inflammatory steroid component. However, the lower strength is approved for use as both maintenance and as-needed reliever therapy (MART) for sudden symptoms.
Q: What are the most commonly reported side effects when first starting ДуоРесп Спиромакс?
A: Common side effects listed in official information include headache, tremor (shaking), and palpitations (awareness of the heart beat). Regulatory documents note that these effects, particularly tremor and palpitations, may be transient and can be more noticeable when treatment is initiated.
Q: How long does the effect of one dose of ДуоРесп Спиромакс typically last?
A: The medicine contains Formoterol, which is classified as a long-acting beta-agonist (LABA), providing sustained widening of the airways. Regulatory information indicates its long-acting profile provides extended bronchodilation, although a precise hourly duration is often not specified in summary documents.
Q: What are the signs that ДуоРесп Спиромакс might not be working effectively for me anymore?
A: Official information outlines expected outcomes, such as reduced frequency of severe asthma attacks and improvements in lung function. A persistent worsening of breathing symptoms or an increased frequency of using the as-needed reliever may be signs that treatment is not maintaining adequate symptom control.
Q: If I accidentally miss a dose, what is the generally accepted advice?
A: Regulatory guidelines state that if a scheduled maintenance dose is missed, it should not be doubled to catch up. The subsequent dose should simply be taken as normal at the next scheduled time.
Q: Why is ДуоРесп Спиромакс prescribed for some people as both maintenance and reliever therapy?
A: This approach is known as Maintenance and Reliever Therapy (MART). It allows the quick onset of the Formoterol component to be used for fast relief while the Budesonide component, an anti-inflammatory, is also delivered with each relief inhalation.
Q: Does ДуоРесп Спиромакс ever lose its effectiveness over time (tolerance)?
A: The Budesonide component (the corticosteroid) is known to help prevent the beta2-receptors from becoming less sensitive (desensitization), which can occur with long-term use of bronchodilators alone. This synergistic action helps to maintain the effectiveness of the Formoterol component.
Q: Can ДуоРесп Спиромакс cause a fast heart rate or heart palpitations?
A: Yes, regulatory documents list both palpitations (feeling your heart beat) as a common side effect and tachycardia (increased heart rate) as an uncommon side effect. These are linked to the action of the Formoterol component.
Q: Is it normal to get a sore throat or a hoarse voice after using the Spiromax device?
A: Yes, hoarse voice and sore throat are listed in safety information as potential local side effects. These effects are often temporary and related to the medicine passing through the throat.
Q: Can ДуоРесп Спиромакс affect a person's sleep or cause insomnia?
A: Adverse reaction reports list anxiety as an uncommon reaction. Other effects on the nervous system, such as agitation and restlessness, have also been reported, which may interfere with sleep.
Q: Is it possible for ДуоРесп Спиромакс to cause oral thrush, and how is that prevented?
A: Oral and pharyngeal candidiasis (a fungal infection commonly known as thrush) is a common side effect of the corticosteroid component. The risk of candidiasis is generally mitigated by rinsing the mouth with water and spitting it out immediately after using the inhaler.
Q: Does ДуоРесп Спиромакс help with symptoms caused by exercise or allergies?
A: Official prescribing information indicates that this medicine can be used as an anti-inflammatory reliever therapy to help prevent sudden breathing difficulty caused by both allergens and exercise (exercise-induced bronchoconstriction).
Q: Does ДуоРесп Спиромакс contain lactose, and is that a concern for people with milk allergies?
A: Yes, the inhalation powder contains lactose as an excipient. The regulatory documents advise that this lactose may contain trace amounts of milk proteins, which could potentially cause allergic reactions in individuals with severe milk protein hypersensitivity or allergy.
Q: What are the typical storage instructions for the ДуоРесп Спиромакс inhaler?
A: The inhaler should be stored in a cool, dry place at a temperature below 25 C to protect the powder from heat and moisture. The mouthpiece cover is required to be firmly closed after every use.
Q: Why is it important to carry a separate rescue inhaler even when using ДуоРесп Спиромакс as a maintenance drug?
A: When the medicine is prescribed only for fixed, twice-daily maintenance, official guidelines require that a separate short-acting reliever inhaler (SABA) be available. This is necessary for the relief of sudden, acute breathing symptoms.
Q: Can ДуоРесп Спиромакс cause shakiness or tremors in the hands?
A: Yes, tremor (shaking) is a commonly reported adverse reaction in clinical studies. Regulatory documents note that this effect may be transient and can be more noticeable when treatment is initiated.
Q: How do I know if I'm using the Spiromax inhaler correctly to get the full dose?
A: Official administration guidelines require the user to inhale forcefully and deeply through the mouthpiece. Some patient information notes that successful dose delivery may result in tasting a slight powder or lactose residue.
Q: How does the dose counter on the ДуоРесп Спиромакс inhaler work?
A: The inhaler has a dose indicator that shows the number of remaining doses. It functions by counting down with each inhalation. Patient information typically indicates that a replacement inhaler should be considered when the remaining doses start to display in the color red.
Q: Is the Spiromax device itself different from other inhaler devices like a Turbuhaler or MDI?
A: Yes, the Spiromax is a unique multi-dose Dry Powder Inhaler (DPI) device. It differs from a metered-dose inhaler (MDI) because it does not use a chemical propellant, and its breath-actuated design ensures the delivery of the powder dose as the user inhales.
Q: What is the recommended cleaning procedure for the Spiromax device?
A: The inhaler must not be washed or placed in water. To clean the device, the mouthpiece should be wiped inside and outside with a clean, dry, lint-free cloth or tissue to remove any excess powder residue.
Q: If I am switching from a different inhaler, what should I expect when starting ДуоРесп Спиромакс?
A: Official guidance for transferring patients notes that full therapeutic benefit may require several weeks. If transferring from long-term oral corticosteroid therapy, some patients may experience allergic or arthritic symptoms during the changeover.
Q: What is the significance of the different strength combinations (e.g., 200/6 vs 400/12)?
A: The different strength combinations are used for different treatment goals. The higher strength, such as 320mu g/9mu g, is restricted to use for fixed maintenance therapy only and is not approved for use as an as-needed reliever for acute symptoms, unlike the lower strengths.
Q: Can ДуоРесп Спиромакс affect blood sugar levels, especially for people with diabetes?
A: Yes, official safety information requires caution in patients with known diabetes mellitus. Hyperglycaemia (elevated blood sugar levels) has been reported as an adverse reaction in clinical experience.
Q: Does this medication contain any propellant chemicals?
A: No. ДуоРесп Спиромакс is a Dry Powder Inhaler (DPI) and is designed to use the force of the patient’s inhalation to carry the medication into the lungs. It does not contain pressurized chemical propellants, which are typically found in Metered Dose Inhalers (MDIs).
Q: What is the maximum number of inhalations that can be taken in a single day?
A: For patients using the medicine under the Maintenance and Reliever Therapy (MART) protocol, the total number of inhalations taken in a single day for both maintenance and relief must not exceed 12 inhalations for a limited period.
Q: Can ДуоРесп Спиромакс cause changes in mood or anxiety?
A: Yes, anxiety is listed as an uncommon adverse reaction in official safety documents. Other reported effects related to the nervous system include agitation, restlessness, and general changes in mood.
Q: If I feel better, should I stop taking ДуоРесп Спиромакс, or continue as prescribed?
A: As a maintenance therapy designed to control chronic airway inflammation, the medicine is intended for use every day regardless of symptom severity. Official guidelines state that it must not be stopped abruptly, and any dose adjustments or discontinuation should only be made under the guidance of a healthcare professional.
Q: What are the less common, but more serious, side effects that require medical attention?
A: Serious adverse reactions documented in official product labels include a sudden and severe narrowing of the airways (paradoxical bronchospasm) immediately after use, signs of adrenal gland suppression, or serious heart rhythm issues (arrhythmias). Regulatory documents indicate that if these serious effects occur, immediate medical attention should be sought.
Q: Does ДуоРесп Спиромакс affect the immune system in the lungs?
A: The Budesonide component (an inhaled corticosteroid) works to reduce inflammation in the airways by affecting the local immune response. Official warnings also note that using the medicine may potentially mask the signs of an infection.
Q: Can the medication cause a cough right after using the inhaler?
A: Yes, a cough is listed as a potential local side effect. This is generally linked to irritation caused by the powder in the throat or mouth.
Q: What is the expiration or shelf life of ДуоРесп Спиромакс after opening the foil wrap?
A: To maintain product integrity, the inhaler has a defined shelf life once the protective foil wrap is opened. Depending on the specific product label, it must be discarded after either 6 months or 12 months from the opening date.
